Health and resource organizations will host free testing events across locations in Dallas on Friday for National HIV Testing ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Users on Facebook, Instagram and X have shared the same “BREAKING NEWS” message, claiming that “A CURE FOR HIV/AIDS HAS JUST ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Hypertension, cigarette smoking, reduced high-density lipoprotein cholesterol, and HIV viral load were modifiable risk factors for primary MACE in patients with HIV on ART.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

Prevention Point Philadelphia, a nonprofit, has been on the front lines of harm reduction for more than 30 years.

University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells’ transportation ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...